J. Driggers

发表

Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen‐Bethesda assay for factor VIII inhibitors

C. Bean, C. Miller, A. Payne, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

A significant proportion of children of African descent with HbSβ0 thalassaemia are inaccurately diagnosed based on phenotypic analyses alone

M. DeBaun, C. Bean, M. Rodeghier, 2019, British journal of haematology.

Magnetic resonance angiography‐defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose‐6‐phosphate dehydrogenase mutation in children with sickle cell anaemia

Bruce A. Vendt, R. McKinstry, M. DeBaun, 2012, British journal of haematology.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

W. Hooper, C. Miller, J. Soucie, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Mutation analysis of a cohort of US patients with hemophilia B

W. Hooper, C. Miller, A. Payne, 2014, American journal of hematology.

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2012, Blood.

cell disease reduced incidence of acute chest syndrome among children with sickle Heme oxygenase-1 gene promoter polymorphism is associated with

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2013 .

Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors

C. Miller, C. Bean, A. Payne, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Stability of specimens for use in the Centers for Disease Control and Prevention assays for factor VIII and IX inhibitors

C. Miller, C. Bean, B. Boylan, 2022, Research and Practice in Thrombosis and Haemostasis.

Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab

C. Miller, C. Bean, B. Boylan, 2020, International Journal of Laboratory Hematology.

Evaluation of pre‐analytic heat treatment protocol used in the CDC Nijmegen‐Bethesda assay for heat inactivation of extended half‐life haemophilia treatment products

C. Miller, C. Bean, D. Ellingsen, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.